Our Sept issue marks our 5th anniversary!🥳 Including #LowBackPain, pneumococcal #vaccination, #JIA, #Sjögrens disease, plus much more! thelancet.com/journals/lanrh… Cover by Chiara Vercesi A huge thank you to all of our contributors over the past 5 years!

Must read in The Lancet Infectious Diseases The first real-world study on the rVSV-ZEBOV vaccine's effectiveness against Ebola virus. This retrospective test-negative study shows an impressive 84% effectiveness outside clinical trials.thelancet.com/journals/lanin…

Here our news work on #mpox Community-based mpox and sexually transmitted disease surveillance using discarded condoms in the global south : covering 16 countries we #surveillance the #mpox #transmission in the #global #South together with #STD #monkeypox #mpxv #surveillance

LFDs are of course great for lots of pathogens. But we tested 5 different commercial #Mpox *antibody* LFDs to see their utility for diagnostic/surveillance use, and they aren't great...from 0% to 56% sensitive! thelancet.com/journals/lanin…

New research: Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial thelancet.com/journals/lanin…

Linked comment: Weighing up monoclonals and vaccination against COVID-19 thelancet.com/journals/lanin…